Fact.MR – A Market Research and Competitive Intelligence Provider: As per Fact.MR, the global serological transplant diagnostics market is projected to expand at a CAGR of 2.5% during the forecast period, 2021-2031 on the back of rapid advancements in the medical and diagnostic sectors.
China to Maintain its Leading Position in the Global Serological Transplant Diagnostics Market: Fact MR
The serological transplant diagnostics market study by Fact MR offers compelling insights into key growth drivers and restraints impacting growth through 2031. The survey offers serological transplant diagnostics demand outlook and studies opportunities existing in key segments, including product and applications. It also highlights key strategies adopted by market players to increase serological transplant diagnostics sales.
Fact.MR – A Market Research and Competitive Intelligence Provider: As per Fact.MR, the global serological transplant diagnostics market is projected to expand at a CAGR of 2.5% during the forecast period, 2021-2031 on the back of rapid advancements in the medical and diagnostic sectors.
The demand for advanced therapeutic procedures is increasing as the prevalence of organ failures such as kidney, lungs, and heart rises. As a result, the use of serological transplant diagnostics has expanded in a variety of applications, including lung transplantation, kidney transplantation, and heart transplantation, indicating that the market is expected to grow.
Rapid technological improvements in organ transplantation techniques will open up new industry prospects.
For Critical Insights On This Market, Request For More Info
https://www.factmr.com/connectus/sample?flag=S&rep_id=5566
Reagents and accessories have emerged as the most popular product, according to Fact.MR. Various forms of serological transplant diagnostic techniques, such as Human Leukocyte Antigens (HLA) testing, blood type testing, and other serological assays, require reagents and accessories.
They are critical for successful organ transplantation, which will continue to be the segment’s key growth driver.
Aside from that, rising hospital demand is boosting the growth of the serological transplant diagnostics market. The European Union’s (EU) hospitals and healthcare sector, according to the European Commission (EC), is rapidly developing and employs about 2% of the EU’s total manufacturing workforce.
The market for serological transplant diagnostics in China is predicted to increase rapidly, according to a Fact.MR analysis, due to the rising prevalence of lungs and renal illnesses and the presence of a well-developed diagnostics industry.
“Government initiatives undertaken to encourage research and development concerning transplant programs will create sales opportunities for serological transplant diagnostics market over the forecast period” says Fact.MR analyst.
Key Takeaways from Serological Transplant Diagnostics Market
- The German market is experiencing strong growth in Europe, owing to increased demand from blood banks and hospitals.
- Due to the rising number of cases of lung, heart, and kidney failure in India, the country is likely to become a lucrative market.
- China’s growth will be aided by the expansion of healthcare infrastructure.
- In the United States, the rising frequency of cardiac disease will continue to aid expansion.
- The use of serological transplant diagnostics for kidney and liver transplantation will continue to rise.
Key Drivers
- As the rate of organ failure rises, so does the demand for serological transplant diagnostics.
- Technological developments in organ transplant operations are driving expansion in the serological transplant diagnostics market.
- A growing number of hospitals are also contributing to the industry’s growth.
Key Restraints
- The market’s expansion is being stifled by the high cost of serological transplant diagnostics.
- Sales of the market will be hampered by a lack of awareness and information about timely diagnosis.
To know more about our research on Serological Transplant Diagnostics Market, you can get in touch with our Analyst:
https://www.factmr.com/connectus/sample?flag=AE&rep_id=5566
Competitive Landscape
To strengthen their product range, industry participants are focused on new product launches, for example, Bio-Rad Laboratories, Inc, a global leader in life science research and clinical diagnostic products announced the release of a blood-based immunoassay kit to detect antibodies to the coronavirus SARS-CoV-2 in 2020. The essay’s initial performance has been accepted; however, the kit is currently undergoing clinical examination in hospitals to further verify clinical performance.
Other market competitors are concentrating on expansions in order to gain a competitive advantage. In 2020, Siemens Healthineers, for example, expanded its serological testing area to include SARS-CoV-2 Testing in order to meet the market’s demand for high-quality tests and expand its sales footprint.
Some of the key players operating in the serological transplant diagnostics market profiled by Fact.MR are:
- Becton Dickinson & Company
- ThermoFisher Scientific Inc.
- Bio-Rad Laboratories Inc.
- Agena Bioscience Inc.
- Avioq Inc.
- Bag Health Care GmbH
- Immucor Inc.
- Siemens Healthineers
- Produkte GmbH
More Valuable Insights on Serological Transplant Diagnostics Market
Fact.MR, in its new report, offers an unbiased analysis of the global serological transplant diagnostics market, analyzing forecast statistics through 2021 and beyond. The survey reveals growth projections on serological transplant diagnostics market with detailed segmentation:
Product
- Reagents & Accessories
- Systems
Application
- Kidney Transplantation
- Liver Transplantation
- Heart Transplantation
- Lung Transplantation
- Others
Distribution Channel
- Hospitals
- Blood Banks & Transplant Centres
- Donor Registries & Research Laboratories
Region
- North America
- Latin America
- Europe
- Middle East and Africa (MEA)
- East Asia
- South Asia
- Oceania
Key Questions Covered in the Serological Transplant Diagnostics Market Report
- The market survey also highlights projected sales growth for serological transplant diagnostics market between 2021 and 2031
- The report offers insight into serological transplant diagnostics demand outlook for forecast period 2021-2031
- Serological transplant diagnostics market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, collaborations or partnerships, and others
- Serological transplant diagnostics market analysis identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry
Explore Fact.MR’s Coverage on the Healthcare Domain –
Diabetes Diagnostics Market Insights - The global diabetes diagnostics market is growing at a rapid pace, owing to the rising prevalence of diabetes. Obesity is well-known as one of the major risk factors for diabetes. As a result of the rising prevalence of obesity, the diabetes diagnostics market will see increased growth.
Home Diagnostics Market Analysis - In a globe grappling with the COVID-19 pandemic, home diagnostics is a rapidly growing sector. Home diagnostic kits enable customers to evaluate and monitor their health conditions in the comfort of their own homes, thanks to innovative technology.
Blood Transfusion Diagnostics Market Forecast - The recent COVID-19 epidemic has provided prospects for growth in the blood transfusion diagnostics market. Patients facing the disease are expected to benefit from this “convalescent plasma.” The global blood transfusion diagnostics market is expected to grow as a result of these factors.
Rapid Medical Diagnostic Kits Market Scope - Infectious disease incidence has been steadily increasing over the last few decades, driving up demand for rapid medical diagnostic kits around the world. The need to detect novel pathogens that cause diseases is propelling the market forward.
About Fact.MR
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology to even the most niche categories. 80% of Fortune 1000’s trust us in critical decision making.
MarketNgage is powered by Fact.MR – our Unified Intelligence Engine, a revolutionary Market Research Subscription platform with a flexible pricing to suit your needs.
You can access all our technology research reports by signing up with MarketNgage’s Market Research Subscription with FREE credits. MarketNgage is powered by Fact.MR – A Fully integrated research solution for seamless single-window access Widest coverage on emerging markets, nascent products, and disruptive technologies.
Contact:
Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Source: Fact.MR